Episode 218 - JD Finley & Mitch Jones - Palisade Bio

from The BioHub - by Avetix · host Max Brennan - Biotech HeadHunter

On this episode we're joined by Palisade Bio's CEO & CMO, JD Finley & Mitch Jones.In Q2 2026, Palisade released promising ph1 data for their lead asset - PALI2108 - a PDE4 inhibitor. With recent IND clearance for their ph2 ASCENTRA-UC study, we discuss that data, and what real success looks like clinically & commercially for the business & asset moving forward, in an increasingly busy IBD market. We hope you enjoy the episode.

Episode metadata supplied by the publisher feed · Published Aug 31, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 218 - JD Finley & Mitch Jones - Palisade Bio

0:00 23:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub - by Avetix?

This episode is 23 minutes long.

When was this The BioHub - by Avetix episode published?

This episode was published on August 31, 2026.

Can I download this The BioHub - by Avetix episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!